Search - tctmd.com

Displaying 41 - 60 of 186

Sort: Relevancy | Date

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

Presentation TCT 2022

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Marc Bonaca

September 17, 2022

Presentation TCT 2022

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

Presenter: Craig Beavers

September 16, 2022

Presentation TCT 2021

What About Anticoagulation Alone?

Presenter: Teresa Carman

November 06, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Connie Hess

November 06, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

Presentation TCT 2021

Controversies Surrounding Transcatheter Devices: Durability, Anticoagulation, Conduction, and More

Presenter: Josep Rodés-Cabau

November 04, 2021

Presentation TCT 2021

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

Presenter: Peter Sayegh

November 04, 2021

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

News Conference News TCT 2021

LAA Closure Feasible in Patients With Thrombus: Registry

Michael O'Riordan

October 13, 2021

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

FlowTriever Looks Good for Acute PE in Interim FLASH Results

Todd Neale

October 18, 2020

Advertisement

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

FLASH: More Data to Support Mechanical Thrombectomy in PE

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

What About Anticoagulation Alone?

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Oral Anticoagulation Should Be the Default Strategy After LAAC

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

More DAPT Duration Data, More Calls to Tailor to Individual Patients

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Controversies Surrounding Transcatheter Devices: Durability, Anticoagulation, Conduction, and More

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

No Harm From Thrombolytics in SCAD Patients With STEMI

LAA Closure Feasible in Patients With Thrombus: Registry

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

FlowTriever Looks Good for Acute PE in Interim FLASH Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content